Switpride MP1 Tablet ER
Marketer
Lifecare Neuro Products Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Switpride MP1 Tablet ER
Diapride ER tablets are a dual-action medication formulated to manage blood glucose. This medication complements diet and exercise to enhance glycemic control in adult patients with type 2 diabetes. It facilitates improved insulin utilization, resulting in reduced blood sugar. Diapride ER dosage and frequency should strictly adhere to your physician's instructions. Administer with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; in this case, omit the missed dose and resume the regular regimen. Never double the dose. An overdose can trigger hypoglycemia (low blood sugar). Concomitant use with other antidiabetic medications, alcohol consumption, or meal skipping may increase the risk of hypoglycemia. Regular blood glucose monitoring is crucial during treatment. Common adverse effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any pre-existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating women must seek medical counsel before use. Your doctor will conduct kidney function assessments before initiating therapy. Limit alcohol consumption as this may heighten the risk of certain side effects.
Uses of Switpride MP1 Tablet ER
Managing type 2 diabetes
Major Benefits of Switpride MP1 Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to the advised dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Switpride MP1 Tablet ER should be administered with a meal.
Common Side effects of Switpride MP1 Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Switpride MP1 Tablet ER:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Switpride MP1 Tablet ER should be administered with food.
How Switpride MP1 Tablet ER works:
Switpride MP1 ER tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications employ distinct mechanisms to optimize blood sugar management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, complements this action by further improving insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Switpride MP1 Tablet ER is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Switpride MP1 Tablet ER during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Patient consultation with a doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Switpride MP1 tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Exercise caution when administering MP1 Switpride Extended-Release tablets to individuals with impaired renal function. Dosage modification may be necessary. Physician consultation is recommended. The use of MP1 Switpride Extended-Release tablets is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Switpride MP1 Tablet ER cautiously, potentially requiring dose modification. Physician consultation is advised. Switpride MP1 Tablet ER is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Switpride MP1 Tablet ER :
Should you forget a dose of Switpride MP1 Tablet ER, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Switpride MP1 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |



